Disc Medicine, Inc.
Total Trades
100
Buys
6
Sells
69
Largest Trade
$1M+
Insiders
15
Institutional Funds
151
Inst. Value
$1M+
Activist Filings
48
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Savage William Jacob | Chief Medical Offi… | SELL | $100K–$500K | 7K | $65.88 | Mar 4, 2026 |
| Franchi Jean M. | CFO | SELL | $15K–$50K | 353 | $69.06 | Feb 27, 2026 |
| Khara Rahul | Chief Legal Officer | SELL | $100K–$500K | 3K | $62.86 | Feb 18, 2026 |
| Stephenson Pamela | Chief Commercial O… | SELL | $100K–$500K | 6K | $62.86 | Feb 18, 2026 |
| Savage William Jacob | Chief Medical Offi… | SELL | $100K–$500K | 3K | $62.86 | Feb 18, 2026 |
| Yu Jonathan Yen-Wen | COO | SELL | $100K–$500K | 3K | $62.86 | Feb 18, 2026 |
| Quisel John D | CEO | SELL | $500K+ | 13K | $62.86 | Feb 18, 2026 |
| Khara Rahul | Chief Legal Officer | SELL | $50K–$100K | 1K | $69.74 | Jan 21, 2026 |
| Khara Rahul | Chief Legal Officer | EXERCISE | $1K–$15K | 1K | $13.50 | Jan 21, 2026 |
| Khara Rahul | Chief Legal Officer | EXERCISE | $50K–$100K | 7K | $13.50 | Jan 6, 2026 |
| Khara Rahul | Chief Legal Officer | SELL | $500K+ | 7K | $78.69 | Jan 6, 2026 |
| Bitterman Kevin | Director | SELL | $50K–$100K | 754 | $91.47 | Dec 18, 2025 |
| Bitterman Kevin | Director | EXERCISE | $50K–$100K | 7K | $13.50 | Dec 17, 2025 |
| Bitterman Kevin | Director | SELL | $1M+ | 184K | $91.56 | Dec 17, 2025 |
| Savage William Jacob | Chief Medical Offi… | SELL | $1M+ | 13K | $91.22 | Dec 17, 2025 |
| Quisel John D | CEO | SELL | $1M+ | 40K | $93.05 | Dec 15, 2025 |
| Quisel John D | CEO | EXERCISE | $100K–$500K | 40K | $9.86 | Dec 15, 2025 |
| Yu Jonathan Yen-Wen | COO | SELL | $1M+ | 30K | $84.70 | Nov 14, 2025 |
| Yu Jonathan Yen-Wen | COO | EXERCISE | $50K–$100K | 30K | $2.65 | Nov 14, 2025 |
| AI DMI LLC | 10% Owner | SELL | $1M+ | 744K | $80.47 | Oct 24, 2025 |
| Bitterman Kevin | Director | SELL | $100K–$500K | 2K | $61.03 | Aug 26, 2025 |
| Bitterman Kevin | Director | SELL | $500K+ | 8K | $61.04 | Aug 1, 2025 |
| Bitterman Kevin | Director | SELL | $1M+ | 43K | $61.03 | Jul 25, 2025 |
| Bitterman Kevin | Director | SELL | $15K–$50K | 664 | $61.13 | Jul 22, 2025 |
| Franchi Jean M. | CFO | SELL | $100K–$500K | 2K | $59.00 | Jul 18, 2025 |
| Franchi Jean M. | CFO | SELL | $100K–$500K | 2K | $57.50 | Jul 15, 2025 |
| Quisel John D | CEO | EXERCISE | $100K–$500K | 35K | $9.86 | Jul 11, 2025 |
| Quisel John D | CEO | SELL | $1M+ | 35K | $55.33 | Jul 11, 2025 |
| Quisel John D | CEO | EXERCISE | $50K–$100K | 5K | $9.86 | Jul 9, 2025 |
| Quisel John D | CEO | SELL | $100K–$500K | 5K | $55.09 | Jul 9, 2025 |
| Franchi Jean M. | CFO | SELL | $100K–$500K | 2K | $52.26 | Jun 18, 2025 |
| Savage William Jacob | Chief Medical Offi… | SELL | $100K–$500K | 3K | $50.00 | Jun 10, 2025 |
| Savage William Jacob | Chief Medical Offi… | SELL | $100K–$500K | 7K | $50.04 | May 22, 2025 |
| Savage William Jacob | Chief Medical Offi… | SELL | $100K–$500K | 2K | $50.17 | May 7, 2025 |
| Ashiya Mona | Director | SELL | $100K–$500K | 6K | $54.11 | Mar 26, 2025 |
| ORBIMED ADVISORS LLC | Director | SELL | $100K–$500K | 6K | $54.11 | Mar 26, 2025 |
| Ashiya Mona | Director | SELL | $1M+ | 52K | $54.02 | Mar 22, 2025 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 52K | $54.02 | Mar 22, 2025 |
| Ashiya Mona | Director | SELL | $1M+ | 312K | $54.31 | Mar 13, 2025 |
| ORBIMED ADVISORS LLC | Director | SELL | $1M+ | 312K | $54.31 | Mar 13, 2025 |
| Stephenson Pamela | Chief Commercial O… | SELL | $100K–$500K | 3K | $54.58 | Feb 21, 2025 |
| Khara Rahul | Chief Legal Officer | SELL | $50K–$100K | 1K | $54.58 | Feb 21, 2025 |
| Savage William Jacob | Chief Medical Offi… | SELL | $50K–$100K | 2K | $54.58 | Feb 21, 2025 |
| Yu Jonathan Yen-Wen | COO | SELL | $50K–$100K | 2K | $54.58 | Feb 21, 2025 |
| Franchi Jean M. | CFO | SELL | $100K–$500K | 3K | $54.58 | Feb 21, 2025 |
| Quisel John D | CEO | SELL | $100K–$500K | 6K | $54.58 | Feb 21, 2025 |
| Khara Rahul | Chief Legal Officer | EXERCISE | $100K–$500K | 8K | $14.69 | Jan 6, 2025 |
| Khara Rahul | Chief Legal Officer | SELL | $100K–$500K | 8K | $62.75 | Jan 6, 2025 |
| Quisel John D | CEO | EXERCISE | $100K–$500K | 23K | $6.01 | Jan 3, 2025 |
| Quisel John D | CEO | SELL | $500K+ | 13K | $61.95 | Jan 3, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 151 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 2.0M | $1M+ | SH |
| VANGUARD GROUP INC | 1.5M | $1M+ | SH |
| Atlas Venture Life Science Advisors, LLC | 1.5M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 1.3M | $1M+ | SH |
| STATE STREET CORP | 1.2M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 1.1M | $1M+ | SH |
| Siren, L.L.C. | 988K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 590K | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 532K | $1M+ | SH |
| First Light Asset Management, LLC | 523K | $1M+ | SH |
| Logos Global Management LP | 510K | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 451K | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 395K | $1M+ | SH |
| Pictet Asset Management Holding SA | 394K | $1M+ | SH |
| JPMORGAN CHASE & CO | 379K | $1M+ | SH |
| Assenagon Asset Management S.A. | 358K | $1M+ | SH |
| Palo Alto Investors LP | 317K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 247K | $1M+ | SH |
| Aberdeen Group plc | 234K | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 231K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Jan 7, 2026
5.9%
2.2M shares
SC 13D/A · Dec 18, 2025
2.2%
813K shares
SC 13G/A · Nov 5, 2025
14.1%
4.9M shares
SC 13D/A · Oct 23, 2025
8.0%
3.0M shares
SC 13D/A · Aug 15, 2025
3.1%
1.1M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Aug 14, 2025
3.0%
1.0M shares
Wellington Management Group LLP
SC 13G/A · Aug 12, 2025
4.1%
1.4M shares
SC 13G/A · Aug 7, 2025
12.2%
4.2M shares
Paradigm BioCapital Advisors LP
SC 13G/A · May 15, 2025
3.5%
1.2M shares
Wellington Management Group LLP
SC 13G · May 12, 2025
6.8%
2.3M shares
SC 13G/A · May 12, 2025
9.3%
3.2M shares
SC 13D/A · Mar 12, 2025
4.5%
1.6M shares
SC 13D/A · Mar 3, 2025
10.8%
3.8M shares
Bain Capital Life Sciences Opportunities III, LP
SC 13G/A · Feb 14, 2025
3.3%
984K shares
SC 13G · Feb 12, 2025
6.3%
1.9M shares
Wellington Management Group LLP
SC 13G/A · Feb 10, 2025
4.7%
1.4M shares
Bain Capital Life Sciences Opportunities III, LP 2
SC 13G/A · Nov 14, 2024
6.0%
1.8M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G · Nov 8, 2024
6.2%
1.9M shares
Wellington Management Group LLP
SC 13G · Nov 8, 2024
6.2%
1.8M shares
SC 13G · Oct 24, 2024
6.2%
1.9M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13G · Jun 25, 2024
3.7%
1.1M shares
SC 13D/A · Jun 20, 2024
6.0%
1.8M shares
SC 13D/A · Jun 20, 2024
12.6%
3.8M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Bain Capital Life Sciences Opportunities III, LP 2
SC 13G/A · Feb 13, 2024
5.5%
1.3M shares
SC 13D/A · Jan 25, 2024
5.8%
1.4M shares
SC 13D/A · Dec 15, 2023
7.1%
1.7M shares
SC 13D/A · Nov 13, 2023
13.7%
3.3M shares
SC 13D/A · Sep 21, 2023
7.0%
1.6M shares
SC 13G · Jun 30, 2023
5.2%
1.2M shares
SC 13G/A · Jun 28, 2023
4.8%
1.1M shares
SC 13D/A · Jun 21, 2023
10.2%
2.3M shares
SC 13D/A · Jun 20, 2023
14.9%
3.3M shares
Bain Capital Life Sciences Opportunities III, LP
SC 13G · Feb 24, 2023
10.0%
2.0M shares
SC 13D/A · Feb 17, 2023
16.6%
3.1M shares
SC 13D/A · Feb 16, 2023
1.9%
350K shares
SC 13D/A · Feb 14, 2023
1.6%
280K shares
SC 13D/A · Feb 14, 2023
12.9%
2.2M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2023
0.0%
0 shares
SC 13G · Feb 10, 2023
12.7%
2.1M shares
SC 13G/A · Jan 31, 2023
0.0%
0 shares
SC 13D · Jan 9, 2023
16.0%
2.7M shares
SC 13G · Jan 9, 2023
3.0%
500K shares
SC 13D/A · Jan 4, 2023
2.9%
487K shares
SC 13D/A · Jan 3, 2023
12.8%
2.2M shares
SC 13G · Jan 3, 2023
13.8%
2.3M shares